0
Critical Care |

Time to Rethink Sepsis as a Contraindication to Post Cardiac Arrest Therapeutic Hypothermia? A Retrospective Analysis of Outcomes of PCATH With and Without Ensuing Sepsis

Steven Huan-Ling Hsu, MD; Edwin Dominguez, MD; Ravindra Rajmane, MD
Author and Funding Information

New York Downtown Hospital, New York, NY


Chest. 2013;144(4_MeetingAbstracts):424A. doi:10.1378/chest.1704154
Text Size: A A A
Published online

Abstract

SESSION TITLE: Sepsis and Shock Posters

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM

PURPOSE: Improved neurologic outcome has been demonstrated in post-cardiac arrest therapeutic hypothermia (PCATH) due to potential neuroprotective mechanisms. However, infectious complications in PCATH have been increased in out-of-hospital (OHCA) and inpatient cardiac arrest (CA) patients through impaired inflammatory response, increased insulin resistance, and hyperglycemia. Conversely, data are emerging that therapeutic hypothermia (TH) may be beneficial in severe infections in animal model. Our institution excludes patients with sepsis from PCATH. This study seeks to analyze the impact on mortality between patients with uncomplicated TH compared to those with TH who later developed sepsis.

METHODS: Our study is a retrospective chart review of patients with PCATH admitted to New York Downtown Hospital from July 2010 to March 2013. We looked at PCATH patients with and without ensuing sepsis and also at those with OHCA and inpatient CA.

RESULTS: We identified 22 PCATH patients. 27.3% had uncomplicated PCATH and 72.7% had PCATH which later progressed to sepsis. Survival to discharge or transfer was 83.3% for uncomplicated PCATH group (33.3% discharge, 50% transferred) and 12.5% for the PCATH and sepsis group (p=0.004). In subset analysis, 5 were OHCA and 17 were inpatient CA. Between the two groups: incidence of infection were 40% and 76% (p= 0.27), antibiotic use were 40% and 82% (p=0.10), survival to discharge or transfer were 40% and 29.4%, and mortality were 60% and 70%, respectively, which did not achieve statistical significance.

CONCLUSIONS: Our study shows increased survival to discharge or transfer, and reduction in mortality in uncomplicated versus complicated by sepsis PCATH patients. There is no statistical difference in incidence of infection, survival, or mortality between OHCA and inpatient CA patients. We postulate that sepsis that develops after PCATH increases overall mortality.

CLINICAL IMPLICATIONS: Although TH may have a role in protecting neurologic outcomes and potentially, mortality, in sepsis, our study shows worse outcomes for PCATH who develop subsequent sepsis. Further study is needed to evaluate outcomes in patients who present with concomitant sepsis and undergo PCATH.

DISCLOSURE: The following authors have nothing to disclose: Steven Huan-Ling Hsu, Edwin Dominguez, Ravindra Rajmane

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543